The 2023 Alzheimer’s Association International Conference (AAIC) held in Amsterdam, Netherlands (16–20 July 2023) was attended in person by over 7,000 delegates, with even more attending via the online platform. Announcement of results from a landmark phase III trial of donanemab took the spotlight among various newsworthy findings reported at the conference.